How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
Special Investor Relations Forum Announced
Laserscope will be holding a special Investor Relations Forum coinciding with the 2006 American Urological Association Meeting on May 22nd, 2006 . Atthis meeting, Laserscope will be discussing current and future R&D and business development initiatives for our urology and aesthetic product linesas well as unveiling the latest new additions to the Laserscope urology product line. Investors are invited to attend in-person or via a web-castwhich will be announced prior to the event. Those planning to attend in person should contact Laserscope's IR representatives as attendance will belimited.
Management Conference Call
Management of Laserscope will hold a conference call today, Monday, May 1,2006 at 8:00am PT / 11:00am ET to discuss results for the 2006 first quarter.To participate in the call, please dial 800-218-0204 (303-262-2050 for international callers) at least five minutes prior to the start time.Investors will also have the opportunity to listen to the conference call liveon the Internet through Laserscope's website at http://www.laserscope.com .Investors should go to the website a few minutes early, as it may be necessaryto download audio software to access the conference call. A replay of the conference call will be available through Monday, May 8, 2006 , by dialing 800-405-2236 (303-590-3000 for international callers), and entering passcode 11059316. An archive will also be available at Laserscope's website.
Laserscope designs, manufactures, sells and services on a worldwide basis an advanced line of minimally-invasive medical products including medicallaser systems and related energy delivery devices for the office, outpatient surgical center, and hospital markets. More information about Laserscope can be found on its web site at http://www.laserscope.com .
Safe Harbor Statement
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, and is subject to thesafe harbor created by this section. These forward-looking statements include: statements about the expected future benefits resulting from the acquisition of InnovaQuartz, such as increased sales of the IQ stone fiberline and other IQ products, manufacturing and engineering improvements in our existing products designed to reduce the cost of goods sold, enhanced fiberoptic R&D and manufacturing capabilities; statements about Laserscope's futureprofitability and operating results, expected continued momentum of Laserscope's business and growth including new product offerings, such as the InnovaQuartz products, worldwide adoption rates of the treatment of stones, especially intracorporeal lithotripsy, our ability to compete with similarproduct offerings and other therapies for the treatment of stones, market penetration opportunities in advanced fiber optics. These statements aresubject to a number of risks and uncertainties, including: the risk that the InnovaQuartz acquisition may not provide us the expected benefits and could disrupt our business and harm our financial condition, results of operations and cash flows; uncertainties regarding introduction of new technologies competitive to Laserscope's products and the degree to which our current and new products are accepted by customers, which could affect the level of demandfor our products, including the IQ products; uncertainties regarding theimpact that competitive products and therapies as well as private and publicpayer reimbursement levels for stone procedures could have on thecompetitiveness of our current pricing programs, which could adversely impactour financial results; risk of reductions in government and private insurancere imbursement of hospitals and physicians for health care costs, which maynegatively impact hospitals and physicians decisions to purchase our products reducing adoption rates and sales growth; risks that patents and licenses thatwe or InnovaQuartz hold may be challenged, invalidated or circumvented or thatwe may become the subject of intellectual property litigation; the risk that we may be unable to maintain favorable relationships with InnovaQuartz'scurrent customers, uncertainties regarding our ability to compete withcompanies that have significantly greater financial, technical, research and development, manufacturing and marketing resources than we have; and uncertainties that new products will receive regulatory approval in applicablejurisdictions. Actual results may differ materially due to these and otherfactors. The matters discussed in this press release also involve risks and uncertainties described from time to time in Laserscope's filings with the Securities and Exchange Commission. In particular, see the Risk Factors described in Laserscope's most recent Quarterly Report on Form 10-Q and AnnualReport on Form 10-K. Copies of Laserscope's public disclosure filings with the SEC, including the most recent Annual Report on Form 10-K and the mostrecent forms 10-Q are available upon request from its Investor Relations Department at its website at http://www.laserscope.com and at the SEC'swebsite: http://www.sec.gov . Laserscope assumes no obligation to update theforward-looking information contained in this press release.At Laserscope: At Financial Relations Board: Eric Reuter, President & CEO Tricia Ross Analyst/Investor Contact Derek Bertocci, CFO (617) 520-7064 (408) 943-0636
News stories provided by third parties are not edited by "Site Publication" staff. For suggestions and comments, please click the Contact link at the bottom of this page.